Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 12;7(1):3216.
doi: 10.1038/s41598-017-03171-4.

Irregular sleep/wake patterns are associated with poorer academic performance and delayed circadian and sleep/wake timing

Affiliations

Irregular sleep/wake patterns are associated with poorer academic performance and delayed circadian and sleep/wake timing

Andrew J K Phillips et al. Sci Rep. .

Abstract

The association of irregular sleep schedules with circadian timing and academic performance has not been systematically examined. We studied 61 undergraduates for 30 days using sleep diaries, and quantified sleep regularity using a novel metric, the sleep regularity index (SRI). In the most and least regular quintiles, circadian phase and light exposure were assessed using salivary dim-light melatonin onset (DLMO) and wrist-worn photometry, respectively. DLMO occurred later (00:08 ± 1:54 vs. 21:32 ± 1:48; p < 0.003); the daily sleep propensity rhythm peaked later (06:33 ± 0:19 vs. 04:45 ± 0:11; p < 0.005); and light rhythms had lower amplitude (102 ± 19 lux vs. 179 ± 29 lux; p < 0.005) in Irregular compared to Regular sleepers. A mathematical model of the circadian pacemaker and its response to light was used to demonstrate that Irregular vs. Regular group differences in circadian timing were likely primarily due to their different patterns of light exposure. A positive correlation (r = 0.37; p < 0.004) between academic performance and SRI was observed. These findings show that irregular sleep and light exposure patterns in college students are associated with delayed circadian rhythms and lower academic performance. Moreover, the modeling results reveal that light-based interventions may be therapeutically effective in improving sleep regularity in this population.

PubMed Disclaimer

Conflict of interest statement

L.K.B. has previously received research support from Cephalon, NFL charities, Sysco and San Francisco Bar Pilots. She has received consulting/lecture fees or served as a board member for Alertness Solution, Ceridian, Davis Joint Unified School Board, San Jose State University Foundation, Pugot Sound Pilots, Sygma and Torvec. RWP is a co-founder of and shareholder in Empatica Inc and Affectiva Inc and serves on the board of Empatica. She is inventor or co-inventor on over two dozen patents, mostly in the field of affective computing and physiological measurement. She has received royalty payments from MIT for patents licensed to Affectiva, consulting and honorarium payments from Merck, Samsung, Analog Devices, and fees for serving as an expert witness in cases involving wearable sensors from Apple and Intel. Her research is funded in part by a consortium that includes over 70 companies who fund the MIT Media Lab (up to date list is kept online at http://media.mit.edu) and includes project funding supporting her team’s work from Robert Wood Johnson Foundation, The Simons Foundation, The SDSC Global Foundation, NEC, LKK, Cisco, Deloitte, Steelcase, and Medimmune. She has received travel reimbursement from Apple, Future of Storytelling, Mattel/Fisher-Price, Microsoft, MindCare, Motorola, Planetree, Profectum, Sentiment Symposium, Seoul Digital, Silicon Valley Entrepreneurs Network, and Wired. AJKP holds a patent related to estimating physiological states from measurements of sleep and circadian rhythms. SWL has received consulting fees from Perceptive Advisors, Carbon Limiting Technologies Ltd on behalf of PhotoStar LED, Serrado Capital, Atlanta Hawks; and has current consulting contracts with Headwaters Inc., Wyle Integrated Science and Engineering, PlanLED, Delos Living LLC, Environmental Light Sciences LLC, Hintsa Performance AG, Pegasus Capital Advisors LP, Akili Interactive, Focal Point LLC, OpTerra Energy Services Inc., and Light Cognitive. SWL has received unrestricted equipment gifts from Bionetics Corporation and Biological Illuminations LLC; has equity or stock options in iSLEEP, Pty, Melbourne, Australia and Akili Interactive; advance author payment and/or royalties from Oxford University Press; honoraria plus travel, accommodation or meals for invited seminars, conference presentations or teaching from Estee Lauder, Lightfair, and Informa Exhibitions (USGBC); travel, accommodation and/or meals only (no honoraria) for invited seminars, conference presentations or teaching from FASEB, Hintsa Performance AG, Lightfair, and USGBC. SWL has completed investigator-initiated research grants from Biological Illumination LLC and Vanda Pharmaceuticals Inc and has an ongoing investigator initiated grant from F. Lux Software LLC; completed service agreements from Rio Tinto Iron Ore and Vanda Pharmaceuticals Inc.; and completed three sponsor-initiated clinical research contracts from Vanda Pharmaceuticals Inc. SWL holds a process patent for the use of short-wavelength light for resetting the human circadian pacemaker and improving alertness and performance which is assigned to the Brigham and Women’s Hospital per Hospital policy (2005). SWL has also served as a paid expert on behalf of several public bodies on arbitrations related to sleep, light, circadian rhythms and/or work hours for City of Brantford, Canada, and legal proceedings related to light, sleep and health (confidential). SWL is also a Program Manager for the CRC for Alertness, Safety and Productivity, Australia. EBK received travel reimbursement from the Sleep Technology Council and has served as an expert witness in cases involving transportation safety and sleep deprivation. CAC has received consulting fees from or served as a paid member of scientific advisory boards for: Amazon.com, Inc.; A2Z Development Center; Bose Corporation; Boston Celtics; Boston Red Sox; Cephalon, Inc.; Citgo Inc.; Cleveland Browns; Columbia River Bar Pilots; Gerson Lehman Group; Institute of Digital Media and Child Development; Jazz Pharmaceuticals; Koninklijke Philips Electronics, N.V.; Merck & Co. Inc.; Minnesota Timberwolves; Novartis; Portland Trail Blazers; Purdue Pharma; Quest Diagnostics, Inc.; Samsung Electronics; Sleep Multimedia, Inc.; Teva Pharmaceuticals; Valero Inc.; Vanda Pharmaceuticals; and Zeo Inc.. CAC has also received education/research support from Cephalon Inc., Jazz Pharmaceuticals, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, National Football League Charities, Optum, Philips Respironics, ResMed Foundation, San Francisco Bar Pilots, Schneider Inc., Simmons, Sysco and Vanda Pharmaceuticals, Inc. The Sleep and Health Education Program of the Harvard Medical School Division of Sleep Medicine (which CAC directs) has received Educational Grant funding from Cephalon, Inc., Jazz Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Sanofi-Aventis, Inc., Sepracor, Inc. and Wake Up Narcolepsy. CAC is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker). Since 1985, CAC has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms including those involving the following commercial entities: Bombardier, Inc.; Continental Airlines; FedEx; Greyhound; Purdue Pharma, L.P.; and United Parcel Service (UPS). CAC owns or owned an equity interest in Apple, Lifetrac, Inc., Microsoft, Somnus Therapeutics, Inc., Vanda Pharmaceuticals, and Zeo Inc. He received royalties from CNN, McGraw Hill, Houghton Mifflin Harcourt, and Philips Respironics, Inc. for the Actiwatch-2 and Actiwatch-Spectrum devices. CAC’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.

Figures

Figure 1
Figure 1
Two dimensions of sleep: duration and regularity. (A) Average daily sleep duration vs. sleep regularity index (SRI) for all participants (n = 61) assessed across the whole study interval. Participants identified for the Irregular (n = 12) and Regular (n = 12) groups at the study mid-point are red circles and blue squares, respectively. Other individuals are white triangles. As explained in the Methods, the SRI values differed slightly by end of study, so those identified as most extreme at the study midpoint did not necessarily remain most extreme at end of study; however, the differences between Regular and Irregular groups remained highly significant (see Results). Error bars indicate mean and standard deviation for Regular and Irregular groups in both SRI and sleep duration. Sleep patterns for four participants collected using daily diaries are shown using double-plotted raster diagrams, where black bars indicate episodes of sleep and gray bars indicate missing data. Four examples are displayed: (B) an Irregular long sleeper, (C) an Irregular short sleeper, (D) a Regular long sleeper, and (E) a Regular short sleeper.
Figure 2
Figure 2
Sleep/wake and light/dark cycles differ between Regular and Irregular groups. Gray lines show individual data (n = 12 for each sleep/wake panel and n = 11 for each light/dark panel). Colored lines show group mean and standard deviation in one-hour bins, with data for each individual averaged across the whole study interval (i.e., multiple days). Dark gray bars indicate clock night (22:00 to 10:00). Left panels: Sleep/wake rhythm (percentage of time asleep) for (A) Regular and (B) Irregular sleepers. Right panels: Normalized light levels for (C) Regular and (D) Irregular sleepers.
Figure 3
Figure 3
Melatonin secretion is delayed in Irregular sleepers. Top panel: (A) Timing of salivary dim light melatonin onset (DLMO) for Regular (n = 12) and Irregular (n = 12) groups. Individuals in each group are shown as dots, with y-axis position jittered for visibility. Groups means (triangles) and standard deviations (error bars) are shown. Middle two panels: Time course for salivary melatonin concentration are shown for Regular participants in (B) and Irregular participants in (C), along with average sleep midpoint times for the nighttime sleep block for each individual (black dots), with y-axis position jittered for visibility. Gray lines show individuals in 1-h bins. Colored lines with error bars show group mean and standard deviation in 1-h bins. Bottom panel: (D) Actual timing of DLMO vs. model prediction for timing of DLMO, assessed using saliva. Data points correspond to individuals in the Regular (blue square) and Irregular (red circle) groups. Error bars show mean and standard deviation for each group. Differences in group averages are displayed. The dashed lines show linear regressions for each group.
Figure 4
Figure 4
Example of model inputs and outputs for one participant. Variables are shown for days 280–300 of a 300-day simulation for one participant from the Regular group. (A) Binned light levels in lux. (B) The two circadian pacemaker variables, x (blue) and x c (red). (C) The predicted salivary melatonin concentration. (D) The clock-time of Dim Light Salivary Melatonin Onset (DLSMO) on each day.
Figure 5
Figure 5
Correlations between sleep regularity index (SRI), grade point average (GPA), and timing of melatonin secretion. Panels (A, B and C) show the relationships between the variables: SRI, GPA, and salivary DLMO. Dashed lines show the linear fits, with r-values and p-values shown for each linear (Pearson) correlation. Each data point represents an individual, with colors indicating whether the individual was a member of the Regular (blue), Irregular (red), or neither group (black). Note that DLMO was only assessed in the Irregular and Regular participants.

References

    1. Medeiros ALD, Mendes DBF, Lima PF, Araujo JF. The relationships between sleep-wake cycle and academic performance in medical students. Biol. Rhythm Res. 2001;32:263–270. doi: 10.1076/brhm.32.2.263.1359. - DOI
    1. Tsai LL, Li SP. Sleep patterns in college students: Gender and grade differences. J. Psychosomatic Res. 2004;56:231–237. doi: 10.1016/S0022-3999(03)00507-5. - DOI - PubMed
    1. Lund HG, Reider BD. Sleep patterns and predictors of disturbed sleep in a large population of college students. J. Adolesc. Health. 2010;46:124–132. doi: 10.1016/j.jadohealth.2009.06.016. - DOI - PubMed
    1. Taylor DJ, Bramoweth AD. Patterns and consequences of inadequate sleep in college students: substance use and motor vehicle accidents. J. Adolesc. Health. 2010;46:610–612. doi: 10.1016/j.jadohealth.2009.12.010. - DOI - PubMed
    1. Carskadon MA, Sharkey KM, Knopik VS, McGeary JE. Short sleep as an environmental exposure: a preliminary study associating 5-HTTLPR genotype to self-reported sleep duration and depressed mood in first-year university students. Sleep. 2012;35:791–796. doi: 10.5665/sleep.1876. - DOI - PMC - PubMed

Publication types

LinkOut - more resources